Medical Care

Global Cytotoxicity Testing Market Research Report 2025

The global market for Cytotoxicity Testing was valued at US$ 14850 million in the year 2024 and is projected to reach a revised size of US$ 25910 million by 2031, growing at a CAGR of 8.4% during the forecast period.
The Cytotoxicity Test is designed to evaluate the general toxicity of medical devices and materials. Testing involves extracting devices in a cell culture media and then exposing the extract fluid to mouse fibroblast cells.
Cytotoxicity Testing Market: Growing Demand Driven by Rising Pharmaceutical R&D and Regulatory Stringency
The global cytotoxicity testing market is expected to witness significant growth in the coming years, fueled by several key factors:
Rising pharmaceutical research and development: Increased investments in drug discovery and development are leading to a higher demand for cytotoxicity testing services to assess the safety and efficacy of new drugs.
Stringent regulatory requirements: Regulatory agencies like the FDA and EMA are imposing stricter regulations on the safety of drugs and medical devices, mandating comprehensive cytotoxicity testing.
Growing awareness of safety concerns: Increasing awareness about the potential toxicity of drugs, medical devices, and consumer products is driving the demand for cytotoxicity testing to ensure the safety of these products.
Advances in technology: Technological advancements are leading to the development of more sensitive, specific, and high-throughput cytotoxicity testing methods, making them more efficient and cost-effective.
Outsourcing trend: Pharmaceutical and biotechnology companies are increasingly outsourcing their cytotoxicity testing needs to specialized contract research organizations (CROs) due to expertise and cost considerations.
Market Trends:
Integration of automation and data analytics: Integrating cytotoxicity testing with automation and data analytics systems is enhancing efficiency, data traceability, and decision-making capabilities.
Focus on high-throughput screening (HTS): HTS methods are increasingly being used to screen large libraries of compounds for potential cytotoxicity, leading to faster drug discovery and development.
Development of 3D cell culture models: 3D cell culture models are becoming increasingly popular for cytotoxicity testing as they provide a more realistic environment for assessing the effects of substances on living cells.
Focus on personalized medicine: Personalized cytotoxicity testing approaches are being developed to tailor testing protocols to individual patients based on their genetic makeup and other factors.
Technological advancements: Advancements in areas like microfluidics and nanotechnology are leading to the development of new and improved cytotoxicity testing methods.
Challenges and Opportunities:
Stringent regulatory compliance requirements: Maintaining compliance with evolving regulatory requirements can be challenging for testing laboratories, requiring continuous investments in technology and expertise.
Competition from new entrants: The market is becoming increasingly competitive with the entry of new players, putting pressure on established companies to innovate and offer cost-effective solutions.
Rapid technological advancements: Keeping pace with rapid technological advancements and the constant evolution of testing methods requires significant investments in research and development.
The future of the cytotoxicity testing market is optimistic, driven by the increasing demand for safe and effective drugs, medical devices, and consumer products, stringent regulatory requirements, and ongoing technological advancements. By focusing on innovation, automation, cost-effectiveness, and expansion into emerging markets, testing service providers can ensure their competitiveness and contribute to enhancing patient safety and product quality.
This report aims to provide a comprehensive presentation of the global market for Cytotoxicity Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytotoxicity Testing.
The Cytotoxicity Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cytotoxicity Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cytotoxicity Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sartorius
UL
Eurofins
SGS
Emery Pharma
Nelson Labs
UFAG Laboratorien AG
Pacific BioLabs
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
TÜV SÜD
Medicilon
Huatongwei
Segment by Type
Elution Testing Method
Agar Overlay Method
Direct Contact Method
MTT Assay Method
Others
Segment by Application
Medical Device
Medical Accessories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytotoxicity Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytotoxicity Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Elution Testing Method
1.2.3 Agar Overlay Method
1.2.4 Direct Contact Method
1.2.5 MTT Assay Method
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cytotoxicity Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Device
1.3.3 Medical Accessories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cytotoxicity Testing Market Perspective (2020-2031)
2.2 Global Cytotoxicity Testing Growth Trends by Region
2.2.1 Global Cytotoxicity Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cytotoxicity Testing Historic Market Size by Region (2020-2025)
2.2.3 Cytotoxicity Testing Forecasted Market Size by Region (2026-2031)
2.3 Cytotoxicity Testing Market Dynamics
2.3.1 Cytotoxicity Testing Industry Trends
2.3.2 Cytotoxicity Testing Market Drivers
2.3.3 Cytotoxicity Testing Market Challenges
2.3.4 Cytotoxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cytotoxicity Testing Players by Revenue
3.1.1 Global Top Cytotoxicity Testing Players by Revenue (2020-2025)
3.1.2 Global Cytotoxicity Testing Revenue Market Share by Players (2020-2025)
3.2 Global Cytotoxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cytotoxicity Testing Revenue
3.4 Global Cytotoxicity Testing Market Concentration Ratio
3.4.1 Global Cytotoxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytotoxicity Testing Revenue in 2024
3.5 Global Key Players of Cytotoxicity Testing Head office and Area Served
3.6 Global Key Players of Cytotoxicity Testing, Product and Application
3.7 Global Key Players of Cytotoxicity Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cytotoxicity Testing Breakdown Data by Type
4.1 Global Cytotoxicity Testing Historic Market Size by Type (2020-2025)
4.2 Global Cytotoxicity Testing Forecasted Market Size by Type (2026-2031)
5 Cytotoxicity Testing Breakdown Data by Application
5.1 Global Cytotoxicity Testing Historic Market Size by Application (2020-2025)
5.2 Global Cytotoxicity Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cytotoxicity Testing Market Size (2020-2031)
6.2 North America Cytotoxicity Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cytotoxicity Testing Market Size by Country (2020-2025)
6.4 North America Cytotoxicity Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cytotoxicity Testing Market Size (2020-2031)
7.2 Europe Cytotoxicity Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cytotoxicity Testing Market Size by Country (2020-2025)
7.4 Europe Cytotoxicity Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cytotoxicity Testing Market Size (2020-2031)
8.2 Asia-Pacific Cytotoxicity Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cytotoxicity Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cytotoxicity Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cytotoxicity Testing Market Size (2020-2031)
9.2 Latin America Cytotoxicity Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cytotoxicity Testing Market Size by Country (2020-2025)
9.4 Latin America Cytotoxicity Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cytotoxicity Testing Market Size (2020-2031)
10.2 Middle East & Africa Cytotoxicity Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cytotoxicity Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cytotoxicity Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sartorius
11.1.1 Sartorius Company Details
11.1.2 Sartorius Business Overview
11.1.3 Sartorius Cytotoxicity Testing Introduction
11.1.4 Sartorius Revenue in Cytotoxicity Testing Business (2020-2025)
11.1.5 Sartorius Recent Development
11.2 UL
11.2.1 UL Company Details
11.2.2 UL Business Overview
11.2.3 UL Cytotoxicity Testing Introduction
11.2.4 UL Revenue in Cytotoxicity Testing Business (2020-2025)
11.2.5 UL Recent Development
11.3 Eurofins
11.3.1 Eurofins Company Details
11.3.2 Eurofins Business Overview
11.3.3 Eurofins Cytotoxicity Testing Introduction
11.3.4 Eurofins Revenue in Cytotoxicity Testing Business (2020-2025)
11.3.5 Eurofins Recent Development
11.4 SGS
11.4.1 SGS Company Details
11.4.2 SGS Business Overview
11.4.3 SGS Cytotoxicity Testing Introduction
11.4.4 SGS Revenue in Cytotoxicity Testing Business (2020-2025)
11.4.5 SGS Recent Development
11.5 Emery Pharma
11.5.1 Emery Pharma Company Details
11.5.2 Emery Pharma Business Overview
11.5.3 Emery Pharma Cytotoxicity Testing Introduction
11.5.4 Emery Pharma Revenue in Cytotoxicity Testing Business (2020-2025)
11.5.5 Emery Pharma Recent Development
11.6 Nelson Labs
11.6.1 Nelson Labs Company Details
11.6.2 Nelson Labs Business Overview
11.6.3 Nelson Labs Cytotoxicity Testing Introduction
11.6.4 Nelson Labs Revenue in Cytotoxicity Testing Business (2020-2025)
11.6.5 Nelson Labs Recent Development
11.7 UFAG Laboratorien AG
11.7.1 UFAG Laboratorien AG Company Details
11.7.2 UFAG Laboratorien AG Business Overview
11.7.3 UFAG Laboratorien AG Cytotoxicity Testing Introduction
11.7.4 UFAG Laboratorien AG Revenue in Cytotoxicity Testing Business (2020-2025)
11.7.5 UFAG Laboratorien AG Recent Development
11.8 Pacific BioLabs
11.8.1 Pacific BioLabs Company Details
11.8.2 Pacific BioLabs Business Overview
11.8.3 Pacific BioLabs Cytotoxicity Testing Introduction
11.8.4 Pacific BioLabs Revenue in Cytotoxicity Testing Business (2020-2025)
11.8.5 Pacific BioLabs Recent Development
11.9 NorthEast BioLab
11.9.1 NorthEast BioLab Company Details
11.9.2 NorthEast BioLab Business Overview
11.9.3 NorthEast BioLab Cytotoxicity Testing Introduction
11.9.4 NorthEast BioLab Revenue in Cytotoxicity Testing Business (2020-2025)
11.9.5 NorthEast BioLab Recent Development
11.10 Biosafe Ltd
11.10.1 Biosafe Ltd Company Details
11.10.2 Biosafe Ltd Business Overview
11.10.3 Biosafe Ltd Cytotoxicity Testing Introduction
11.10.4 Biosafe Ltd Revenue in Cytotoxicity Testing Business (2020-2025)
11.10.5 Biosafe Ltd Recent Development
11.11 Creative Bioarray
11.11.1 Creative Bioarray Company Details
11.11.2 Creative Bioarray Business Overview
11.11.3 Creative Bioarray Cytotoxicity Testing Introduction
11.11.4 Creative Bioarray Revenue in Cytotoxicity Testing Business (2020-2025)
11.11.5 Creative Bioarray Recent Development
11.12 Evercyte
11.12.1 Evercyte Company Details
11.12.2 Evercyte Business Overview
11.12.3 Evercyte Cytotoxicity Testing Introduction
11.12.4 Evercyte Revenue in Cytotoxicity Testing Business (2020-2025)
11.12.5 Evercyte Recent Development
11.13 IONTOX
11.13.1 IONTOX Company Details
11.13.2 IONTOX Business Overview
11.13.3 IONTOX Cytotoxicity Testing Introduction
11.13.4 IONTOX Revenue in Cytotoxicity Testing Business (2020-2025)
11.13.5 IONTOX Recent Development
11.14 Applied StemCell
11.14.1 Applied StemCell Company Details
11.14.2 Applied StemCell Business Overview
11.14.3 Applied StemCell Cytotoxicity Testing Introduction
11.14.4 Applied StemCell Revenue in Cytotoxicity Testing Business (2020-2025)
11.14.5 Applied StemCell Recent Development
11.15 Xenometrix AG
11.15.1 Xenometrix AG Company Details
11.15.2 Xenometrix AG Business Overview
11.15.3 Xenometrix AG Cytotoxicity Testing Introduction
11.15.4 Xenometrix AG Revenue in Cytotoxicity Testing Business (2020-2025)
11.15.5 Xenometrix AG Recent Development
11.16 TÜV SÜD
11.16.1 TÜV SÜD Company Details
11.16.2 TÜV SÜD Business Overview
11.16.3 TÜV SÜD Cytotoxicity Testing Introduction
11.16.4 TÜV SÜD Revenue in Cytotoxicity Testing Business (2020-2025)
11.16.5 TÜV SÜD Recent Development
11.17 Medicilon
11.17.1 Medicilon Company Details
11.17.2 Medicilon Business Overview
11.17.3 Medicilon Cytotoxicity Testing Introduction
11.17.4 Medicilon Revenue in Cytotoxicity Testing Business (2020-2025)
11.17.5 Medicilon Recent Development
11.18 Huatongwei
11.18.1 Huatongwei Company Details
11.18.2 Huatongwei Business Overview
11.18.3 Huatongwei Cytotoxicity Testing Introduction
11.18.4 Huatongwei Revenue in Cytotoxicity Testing Business (2020-2025)
11.18.5 Huatongwei Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cytotoxicity Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Elution Testing Method
Table 3. Key Players of Agar Overlay Method
Table 4. Key Players of Direct Contact Method
Table 5. Key Players of MTT Assay Method
Table 6. Key Players of Others
Table 7. Global Cytotoxicity Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cytotoxicity Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cytotoxicity Testing Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Cytotoxicity Testing Market Share by Region (2020-2025)
Table 11. Global Cytotoxicity Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Cytotoxicity Testing Market Share by Region (2026-2031)
Table 13. Cytotoxicity Testing Market Trends
Table 14. Cytotoxicity Testing Market Drivers
Table 15. Cytotoxicity Testing Market Challenges
Table 16. Cytotoxicity Testing Market Restraints
Table 17. Global Cytotoxicity Testing Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Cytotoxicity Testing Market Share by Players (2020-2025)
Table 19. Global Top Cytotoxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytotoxicity Testing as of 2024)
Table 20. Ranking of Global Top Cytotoxicity Testing Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Cytotoxicity Testing Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Cytotoxicity Testing, Headquarters and Area Served
Table 23. Global Key Players of Cytotoxicity Testing, Product and Application
Table 24. Global Key Players of Cytotoxicity Testing, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cytotoxicity Testing Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Cytotoxicity Testing Revenue Market Share by Type (2020-2025)
Table 28. Global Cytotoxicity Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Cytotoxicity Testing Revenue Market Share by Type (2026-2031)
Table 30. Global Cytotoxicity Testing Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Cytotoxicity Testing Revenue Market Share by Application (2020-2025)
Table 32. Global Cytotoxicity Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Cytotoxicity Testing Revenue Market Share by Application (2026-2031)
Table 34. North America Cytotoxicity Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Cytotoxicity Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Cytotoxicity Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Cytotoxicity Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Cytotoxicity Testing Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Cytotoxicity Testing Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Cytotoxicity Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Cytotoxicity Testing Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Cytotoxicity Testing Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Cytotoxicity Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Cytotoxicity Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Cytotoxicity Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Cytotoxicity Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Cytotoxicity Testing Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Cytotoxicity Testing Market Size by Country (2026-2031) & (US$ Million)
Table 49. Sartorius Company Details
Table 50. Sartorius Business Overview
Table 51. Sartorius Cytotoxicity Testing Product
Table 52. Sartorius Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 53. Sartorius Recent Development
Table 54. UL Company Details
Table 55. UL Business Overview
Table 56. UL Cytotoxicity Testing Product
Table 57. UL Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 58. UL Recent Development
Table 59. Eurofins Company Details
Table 60. Eurofins Business Overview
Table 61. Eurofins Cytotoxicity Testing Product
Table 62. Eurofins Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 63. Eurofins Recent Development
Table 64. SGS Company Details
Table 65. SGS Business Overview
Table 66. SGS Cytotoxicity Testing Product
Table 67. SGS Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 68. SGS Recent Development
Table 69. Emery Pharma Company Details
Table 70. Emery Pharma Business Overview
Table 71. Emery Pharma Cytotoxicity Testing Product
Table 72. Emery Pharma Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 73. Emery Pharma Recent Development
Table 74. Nelson Labs Company Details
Table 75. Nelson Labs Business Overview
Table 76. Nelson Labs Cytotoxicity Testing Product
Table 77. Nelson Labs Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 78. Nelson Labs Recent Development
Table 79. UFAG Laboratorien AG Company Details
Table 80. UFAG Laboratorien AG Business Overview
Table 81. UFAG Laboratorien AG Cytotoxicity Testing Product
Table 82. UFAG Laboratorien AG Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 83. UFAG Laboratorien AG Recent Development
Table 84. Pacific BioLabs Company Details
Table 85. Pacific BioLabs Business Overview
Table 86. Pacific BioLabs Cytotoxicity Testing Product
Table 87. Pacific BioLabs Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 88. Pacific BioLabs Recent Development
Table 89. NorthEast BioLab Company Details
Table 90. NorthEast BioLab Business Overview
Table 91. NorthEast BioLab Cytotoxicity Testing Product
Table 92. NorthEast BioLab Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 93. NorthEast BioLab Recent Development
Table 94. Biosafe Ltd Company Details
Table 95. Biosafe Ltd Business Overview
Table 96. Biosafe Ltd Cytotoxicity Testing Product
Table 97. Biosafe Ltd Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 98. Biosafe Ltd Recent Development
Table 99. Creative Bioarray Company Details
Table 100. Creative Bioarray Business Overview
Table 101. Creative Bioarray Cytotoxicity Testing Product
Table 102. Creative Bioarray Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 103. Creative Bioarray Recent Development
Table 104. Evercyte Company Details
Table 105. Evercyte Business Overview
Table 106. Evercyte Cytotoxicity Testing Product
Table 107. Evercyte Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 108. Evercyte Recent Development
Table 109. IONTOX Company Details
Table 110. IONTOX Business Overview
Table 111. IONTOX Cytotoxicity Testing Product
Table 112. IONTOX Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 113. IONTOX Recent Development
Table 114. Applied StemCell Company Details
Table 115. Applied StemCell Business Overview
Table 116. Applied StemCell Cytotoxicity Testing Product
Table 117. Applied StemCell Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 118. Applied StemCell Recent Development
Table 119. Xenometrix AG Company Details
Table 120. Xenometrix AG Business Overview
Table 121. Xenometrix AG Cytotoxicity Testing Product
Table 122. Xenometrix AG Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 123. Xenometrix AG Recent Development
Table 124. TÜV SÜD Company Details
Table 125. TÜV SÜD Business Overview
Table 126. TÜV SÜD Cytotoxicity Testing Product
Table 127. TÜV SÜD Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 128. TÜV SÜD Recent Development
Table 129. Medicilon Company Details
Table 130. Medicilon Business Overview
Table 131. Medicilon Cytotoxicity Testing Product
Table 132. Medicilon Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 133. Medicilon Recent Development
Table 134. Huatongwei Company Details
Table 135. Huatongwei Business Overview
Table 136. Huatongwei Cytotoxicity Testing Product
Table 137. Huatongwei Revenue in Cytotoxicity Testing Business (2020-2025) & (US$ Million)
Table 138. Huatongwei Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. Authors List of This Report


List of Figures
Figure 1. Cytotoxicity Testing Picture
Figure 2. Global Cytotoxicity Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cytotoxicity Testing Market Share by Type: 2024 VS 2031
Figure 4. Elution Testing Method Features
Figure 5. Agar Overlay Method Features
Figure 6. Direct Contact Method Features
Figure 7. MTT Assay Method Features
Figure 8. Others Features
Figure 9. Global Cytotoxicity Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Cytotoxicity Testing Market Share by Application: 2024 VS 2031
Figure 11. Medical Device Case Studies
Figure 12. Medical Accessories Case Studies
Figure 13. Others Case Studies
Figure 14. Cytotoxicity Testing Report Years Considered
Figure 15. Global Cytotoxicity Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Cytotoxicity Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Cytotoxicity Testing Market Share by Region: 2024 VS 2031
Figure 18. Global Cytotoxicity Testing Market Share by Players in 2024
Figure 19. Global Top Cytotoxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytotoxicity Testing as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Cytotoxicity Testing Revenue in 2024
Figure 21. North America Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Cytotoxicity Testing Market Share by Country (2020-2031)
Figure 23. United States Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Cytotoxicity Testing Market Share by Country (2020-2031)
Figure 27. Germany Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Cytotoxicity Testing Market Share by Region (2020-2031)
Figure 35. China Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Cytotoxicity Testing Market Share by Country (2020-2031)
Figure 43. Mexico Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Cytotoxicity Testing Market Share by Country (2020-2031)
Figure 47. Turkey Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Cytotoxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Sartorius Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 51. UL Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 52. Eurofins Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 53. SGS Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 54. Emery Pharma Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 55. Nelson Labs Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 56. UFAG Laboratorien AG Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 57. Pacific BioLabs Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 58. NorthEast BioLab Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 59. Biosafe Ltd Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 60. Creative Bioarray Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 61. Evercyte Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 62. IONTOX Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 63. Applied StemCell Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 64. Xenometrix AG Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 65. TÜV SÜD Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 66. Medicilon Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 67. Huatongwei Revenue Growth Rate in Cytotoxicity Testing Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies